tiprankstipranks
Adaptive Biotechnologies (DE:1HM)
NASDAQ:1HM
Germany Market

Adaptive Biotechnologies (1HM) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Adaptive Biotechnologies’s (1HM) Moving Averages Convergence Divergence (MACD) indicator is 1.52, suggesting Adaptive Biotechnologies is a Sell.
Adaptive Biotechnologies’s (1HM) 20-Day exponential moving average is 16.20, while Adaptive Biotechnologies’s (1HM) share price is €12.28, making it a Buy.
Adaptive Biotechnologies’s (1HM) 50-Day exponential moving average is 14.43, while Adaptive Biotechnologies’s (1HM) share price is €12.28, making it a Buy.

Adaptive Biotechnologies (1HM) Pivot Points

Jul 04, 2026, 02:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.50
18.50
18.50
18.50
18.50
18.50
18.50
Fibonacci
18.50
18.50
18.50
18.50
18.50
18.50
18.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptive Biotechnologies (1HM) Moving Averages

Jul 04, 2026, 02:42 PM
Period
Simple
Exponential
MA5
18.67Buy
18.49Buy
MA10
17.08Buy
17.49Buy
MA20
15.98Buy
16.20Buy
MA50
13.53Buy
14.43Buy
MA100
12.93Buy
13.61Buy
MA200
13.43Buy
13.04Buy
Adaptive Biotechnologies’s (1HM) 10-Day exponential moving average is 17.49, while Adaptive Biotechnologies’s (1HM) share price is €12.28, making it a Buy.
Adaptive Biotechnologies’s (1HM) 100-Day exponential moving average is 13.61, while Adaptive Biotechnologies’s (1HM) share price is €12.28, making it a Buy.
Adaptive Biotechnologies’s (1HM) stock price is €12.28 and Adaptive Biotechnologies’s (1HM) 50-day simple moving average is 13.53, creating a Buy signal.
Adaptive Biotechnologies’s (1HM) stock price is €12.28 and Adaptive Biotechnologies’s (1HM) 100-day simple moving average is 12.93, creating a Buy signal.
Adaptive Biotechnologies’s (1HM) stock price is €12.28 and Adaptive Biotechnologies’s (1HM) 200-day simple moving average is 13.43, creating a Buy signal.

Adaptive Biotechnologies (1HM) Technical Indicators

Jul 04, 2026, 02:42 PM
Name
Value
Implied Action
RSI (14)
74.43
Sell
STOCH (9,6)
88.87
Sell
STOCHRSI (14)
90.68
Sell
MACD (12,26)
1.52
Sell
ADX (14)
41.26
Neutral
Williams %R
0.00
Sell
CCI (14)
170.06
Sell
ATR (14)
0.67
-
Ultimate Oscillator
79.65
Buy
ROC
26.92
Buy
Adaptive Biotechnologies’s (1HM) Relative Strength Index (RSI) is 74.43, creating a Sell signal.
Adaptive Biotechnologies’s (1HM) Trend Strength Indicator (ADX) is 41.26, creating a Neutral signal.
Adaptive Biotechnologies’s (1HM) Commodity Channel Index (CCI) is 170.06, creating a Sell signal.
Adaptive Biotechnologies’s (1HM) Price Rate of Change (ROC) is 26.92, creating a Buy signal.

FAQ

Is 1HM a Buy, Hold, or Sell?
Based on 1HM’s technical indicators, 1HM is a Buy.
    What is 1HM’s RSI (14)?
    1HM’s RSI (14) is 74.43, which suggests 1HM is a Sell.
      What is 1HM’s MACD?
      1HM’s MACD is 1.52, which suggests 1HM is a Sell.
        What is 1HM’s 5-day moving average?
        1HM’s 5-day moving average is 18.67, which suggests 1HM is a Buy.
          What is 1HM’s 20-day moving average?
          1HM 20-day moving average is 15.98, which suggests 1HM is a Buy.
            What is 1HM’s 50-day moving average?
            1HM’s 50-day moving average is 13.53, which suggests 1HM is a Buy.
              What is 1HM’s 200-day moving average?
              1HM’s 200-day moving average is 13.43, which suggests 1HM is a Buy.
                What is 1HM’s Williams % R (14)?
                1HM’s Williams % R (14) is 0.00, which suggests 1HM is a Sell.
                  What is 1HM’s CCI (14)?
                  1HM’s CCI (14) is 170.06, which suggests 1HM is a Sell.
                    What is the share price of Adaptive Biotechnologies?